These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
969 related articles for article (PubMed ID: 32155139)
1. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142. Zhang L; Zhao G; Ji S; Yuan Q; Zhou H Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p. Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis. Liu ZB; Wang JA; Lv RQ Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262 [TBL] [Abstract][Full Text] [Related]
4. LncRNA DSCAM-AS1 promoted cell proliferation and invasion in osteosarcoma by sponging miR-101. Yu CL; Xu NW; Jiang W; Zhang H; Ma Y Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7709-7717. PubMed ID: 32744697 [TBL] [Abstract][Full Text] [Related]
5. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression. Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022 [TBL] [Abstract][Full Text] [Related]
6. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway. Li C; Feng S; Chen L Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway. Gao J; Dai C; Yu X; Yin XB; Zhou F J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108 [TBL] [Abstract][Full Text] [Related]
8. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5. Ye F; Tian L; Zhou Q; Feng D Gene; 2019 Dec; 721():144093. PubMed ID: 31473323 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer. Ma T; Chen H; Wang P; Yang N; Bao J Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162 [No Abstract] [Full Text] [Related]
10. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma. Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761 [TBL] [Abstract][Full Text] [Related]
11. LncRNA ADPGK-AS1 regulated cell proliferation, invasion, migration and apoptosis via targeting miR-542-3p in osteosarcoma. Luo XF; Wu XJ; Wei X; Wang AG; Wang SH; Wang JL Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8751-8760. PubMed ID: 31696461 [TBL] [Abstract][Full Text] [Related]
12. Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression. Dai JH; Huang WZ; Li C; Deng J; Lin SJ; Luo J Cell Cycle; 2019 Oct; 18(20):2727-2741. PubMed ID: 31432728 [No Abstract] [Full Text] [Related]
13. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a. Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194 [TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA HNF1A-AS1 Regulates Osteosarcoma Advancement Through Modulating the miR-32-5p/HMGB1 Axis. Lou P; Ding T; Zhan X Cancer Biother Radiopharm; 2021 May; 36(4):371-381. PubMed ID: 32706998 [No Abstract] [Full Text] [Related]
15. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a. Cheng C; Qin Y; Zhi Q; Wang J; Qin C Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815 [TBL] [Abstract][Full Text] [Related]
16. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145. Zhou Y; Feng D; Gu X; Gao A; Liu Y Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416 [TBL] [Abstract][Full Text] [Related]
17. Targeting EZH2 by microRNA-449a inhibits osteosarcoma cell proliferation, invasion and migration via regulation of PI3K/AKT signaling pathway and epithelial-mesenchymal transition. Lu DG; Tang QL; Wei JH; He FY; Lu L; Tang YJ Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1656-1665. PubMed ID: 32141531 [TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression. Li G; Liu K; Du X Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p. Cheng FH; Zhao ZS; Liu WD Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7256-7265. PubMed ID: 31539112 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma. Zhao G; Cai C; Yang T; Qiu X; Liao B; Li W; Ji Z; Zhao J; Zhao H; Guo M; Ma Q; Xiao C; Fan Q; Ma B PLoS One; 2013; 8(1):e53906. PubMed ID: 23372675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]